Open Access. Powered by Scholars. Published by Universities.®
Skin and Connective Tissue Diseases Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Publication
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Skin and Connective Tissue Diseases
An Overview Of Risk Factors For Androgenetic Alopecia Among Women At Pasar Ambacang, Kuranji, Padang, Lidya Aprilia Sugma, Satya Wydya Yenny, Roslaili Rasyid
An Overview Of Risk Factors For Androgenetic Alopecia Among Women At Pasar Ambacang, Kuranji, Padang, Lidya Aprilia Sugma, Satya Wydya Yenny, Roslaili Rasyid
Journal of General - Procedural Dermatology & Venereology Indonesia
Background: Androgenetic alopecia (AGA) is a patterned hair loss due to chronic and progressive miniaturization of hair follicles. Hair represents femininity and self-confidence in women. Therefore, AGA may affect the quality of life and psychology in women. This study aims to describe the risk factors for AGA in women living in Pasar Ambacang Sub-district, Kuranji District, Padang City.
Method: This was a descriptive, cross-sectional study that included 40 women with AGA. Interviews with subjects were conducted. This study was approved by the Health Research Ethics Committee at Universitas Andalas (252/UN.16.2/KEPK-FK/2021)
Results: AGA was mostly found on patients …
Is Minoxidil Efficacious And Safe For The Treatment Of Androgenetic Alopecia (Aga) In Men, And If So, What Is The Optimal Strength And Means Of Delivery?, Anhthu P. Pickart
Is Minoxidil Efficacious And Safe For The Treatment Of Androgenetic Alopecia (Aga) In Men, And If So, What Is The Optimal Strength And Means Of Delivery?, Anhthu P. Pickart
PCOM Physician Assistant Studies Student Scholarship
OBJECTIVE: The objective of this selective EBM review is to determine whether or not minoxidil is efficacious and safe for the treatment of androgenetic alopecia (AGA) in men, and if so, what is the optimal strength and means of delivery.
STUDY DESIGN: Review of three double-blind randomized controlled trials studying men (18-49 y/o) with androgenetic alopecia published in English from 2007-2009.
DATA SOURCES: Three articles of double-blind randomized controlled trials found via PubMed.
OUTCOMES MEASURED: Outcomes measured included the efficacy and safety of minoxidil as well as the optimal strength and means of delivery of the …